Pluri Inc. (PLUR)
NASDAQ: PLUR · Real-Time Price · USD
1.235
+0.045 (3.81%)
At close: Nov 6, 2026, 4:00 PM EST
1.070
-0.165 (-13.38%)
After-hours: Nov 6, 2026, 5:43 PM EST
Pluri Revenue
In the fiscal year ending June 30, 2026, Pluri had annual revenue of $1.02M, down -23.95%. Pluri had revenue of $335.00K in the quarter ending June 30, 2026, a decrease of -15.83%. That makes Pluri the 43,627th largest company in the world by revenue and 6,099th in the United States.
Revenue (ttm)
$1.02M
Revenue Growth
-23.95%
P/S Ratio
15.01
Revenue / Employee
$8,991
Employees
113
Market Cap
15.25M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 1.02M | -320.00K | -23.95% |
| Jun 30, 2025 | 1.34M | 1.01M | 309.82% |
| Jun 30, 2024 | 326.00K | 39.00K | 13.59% |
| Jun 30, 2023 | 287.00K | 53.00K | 22.65% |
| Jun 30, 2022 | 234.00K | - | - |
| Jun 30, 2021 | - | - | - |
| Jun 30, 2020 | 23.00K | -31.00K | -57.41% |
| Jun 30, 2019 | 54.00K | 4.00K | 8.00% |
| Jun 30, 2018 | 50.00K | - | - |
| Jun 30, 2017 | - | - | - |
| Jun 30, 2016 | 2.85M | 2.47M | 651.19% |
| Jun 30, 2015 | 379.00K | - | - |
| Jun 30, 2014 | 379.00K | -300.00K | -44.18% |
| Jun 30, 2013 | 679.00K | -37.00K | -5.17% |
| Jun 30, 2012 | 716.00K | - | - |
| Jun 30, 2011 | - | - | - |
| Jun 30, 2010 | - | - | - |
| Jun 30, 2009 | - | - | - |
| Jun 30, 2008 | - | - | - |
| Jun 30, 2007 | - | - | - |
| Jun 30, 2006 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bolt Biotherapeutics | 4.70M |
| Kyntra Bio | 4.62M |
| Marker Therapeutics | 3.55M |
| Neuphoria Therapeutics | 1.17M |
| Allarity Therapeutics | 345.00K |
| aTyr Pharma | 190.00K |
PLUR News
- 13 days ago - Pluri, ZEO ScientifiX partner to expand regenerative medicine manufacturing - TheFly
- 18 days ago - Pluri chairman Alejandro Weinstein to acquire loan from EIB - TheFly
- 26 days ago - Ever After Foods and Roslin Technologies Achieve Major Leap in Cultivated Meat Productivity - GlobeNewsWire
- 4 weeks ago - Pluri registers to sell 2.29M common shares for holders - TheFly
- 1 month ago - Pluri files $200M mixed securities shelf - TheFly
- 2 months ago - Pluri prices 2.23M shares at $1.50 in registered direct offering - TheFly
- 2 months ago - Pluri Announces Pricing of $3.3 Million Registered Direct Offering and Concurrent Private Placement with a Single Healthcare Focused Institutional Investor - GlobeNewsWire
- 2 months ago - Pluri's Ever After Foods Expands Cultivated-Protein Platform Through Fishway Acquisition and Strategic Investment - GlobeNewsWire